CCN3 (NOV) Is a Negative Regulator of CCN2 (CTGF) and a Novel Endogenous Inhibitor of the Fibrotic Pathway in an in Vitro Model of Renal DiseaseBruce L. Riser, Sarah C. Riser|American Journal Of Pathology|2009Cited by 111
CCN3/CCN2 regulation and the fibrosis of diabetic renal diseaseBruce L. Riser, Darryl R. Peterson|Journal of Cell Communication and Signaling|2010Cited by 49